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Agarwood or gaharu is well known as the most valuable resinous heartwood that occurs in trees of Aquilaria 
species. Depletion of the wild resource from the jungle leads to the high price of agarwood. Thus, there is 
an urgent need to produce agarwood sustainably through agarwood cultivation to meet the global demand 
and induction. This research was conducted to formulate microbial consortia that can be used as fungal 
inoculants for agarwood induction in Aquilaria species. The effectiveness of formulated microbial consortia 
was observed based on the colour and mean length of infected zone formation after a three and six months 
inoculation periods in each wet and dry season, respectively. Aquilaria sp. was inoculated with three types of 
formulated fungal inoculants and negative control by using the bottle drip method. The findings showed that 
F3 inoculant (a combination of Trichoderma sp., Lasiodiplodia sp. and Curvularia sp.) was the most potential 
fungal inoculant for agarwood formation based on the darkest colour and largest mean length of the infected 
zone, after a three and six months inoculation periods for both wet and dry seasons. The formulated inoculant 
is recommended for further development as agarwood fungal inoculant to induce agarwood artificially for 
future sustainable supply of agarwood.
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INTRODUCTION
Agarwood is the dark resinous heartwood that 
occurrs in the trees from Thymelaeaceae family 
including Aquilaria, Gonystulus and Gyrinops spp. 
According to a study by Naef (2011), agarwood is 
the most valuable resinous fragrant wood in the 
world. Its price could go up to USD100,000 per 
kilogram in the market for superior quality and 
high purity  material. Furthermore, agarwood is 
not only well-known for its traits as perfumery 
ingredients and as aroma enhancers in food 
products, but also used as traditional medicine for 
centuries (Lee et al. 2016). In terms of medicinal 
uses of agarwood, it has been recommended as 
an anti-inflammatory agent to treat rheumatism, 
arthritis, body pain, asthma and gout (Hashim 
et al. 2016).
 The lengthy inoculation periods in nature, 
which may take approximately 75 to 80 years 
before the highest yield can be observed, has 
restrained the supply of agarwood in the market 
(Naef 2011, Liu et al. 2013). Therefore, the 
uncertain supply and production of the agarwood 
is the main concern that needs to be addressed 
by researchers to meet the global demand for 
agarwood trading (Barden et al. 2000). In a 
natural forest, only 7–10% of the trees contain 
agarwood. The experienced specialist could 
only deduce the deposit of agarwood by mere 
observation on the intact stem. However, the 
trees still need to be fell and cut open to exactly 
determine the content and quality of the wood 
impregnated with resinoid. Aquilaria malaccensis 
has been listed as the most endangered species 
among all agarwood tree species, as stated in 
Appendix II of the Convention on Internal Trade 
in Endangered Species of Wild Fauna and Flora 
(CITES); unsustainable harvesting of Aquilaria 
sp. in natural forests led to near extinction 
(CITES 2015). Thus, the agarwood needs to be 
artificially induced to maintain the diversity of 
Aquilaria sp., and for the production of a larger 
amount of resin.
 The cultivation of Aquilaria trees has been 
widely practiced in many countries to meet the 
demand for agarwood. Wounding, chemicals 
and microbes inducing agents have been used 
for artificial inoculation (Pojanagaroon & 
Kaewrak 2005, Zhang et al. 2010). In 1952, 
